Last reviewed · How we verify
Test Product 49778 — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Test Product 49778 (Test Product 49778) — Medicis Global Service Corporation.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Test Product 49778 TARGET | Test Product 49778 | Medicis Global Service Corporation | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Test Product 49778 CI watch — RSS
- Test Product 49778 CI watch — Atom
- Test Product 49778 CI watch — JSON
- Test Product 49778 alone — RSS
Cite this brief
Drug Landscape (2026). Test Product 49778 — Competitive Intelligence Brief. https://druglandscape.com/ci/test-product-49778. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing